CR20170106A - COMPOUNDS OF 1-ALQUIL-6-OXO-1, 6-DIHIDROPIRIDIN-3-ILO AND USES OF THE SAME - Google Patents
COMPOUNDS OF 1-ALQUIL-6-OXO-1, 6-DIHIDROPIRIDIN-3-ILO AND USES OF THE SAMEInfo
- Publication number
- CR20170106A CR20170106A CR20170106A CR20170106A CR20170106A CR 20170106 A CR20170106 A CR 20170106A CR 20170106 A CR20170106 A CR 20170106A CR 20170106 A CR20170106 A CR 20170106A CR 20170106 A CR20170106 A CR 20170106A
- Authority
- CR
- Costa Rica
- Prior art keywords
- compounds
- oxo
- dihidropiridin
- alquil
- ilo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La presente invención se refiere en forma general a los compuestos de 1-alquil-6-oxo-1,6-dihidropiridin-3-ilo (incluyendo sales de los mismos). La presente invención asimismo se refiere a las composiciones farmacéuticas y a los kits que comprenden dichos compuestos, a los usos de dichos compuestos (incluyendo métodos de tratamiento y preparación de medicamentos), y a los procesos para preparar dichos compuestosThe present invention relates generally to the 1-alkyl-6-oxo-1,6-dihydropyridin-3-yl compounds (including salts thereof). The present invention also relates to pharmaceutical compositions and kits comprising said compounds, to the uses of said compounds (including methods of treatment and preparation of medicaments), and to the processes for preparing said compounds.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462055822P | 2014-09-26 | 2014-09-26 | |
| PCT/EP2015/071862 WO2016046260A1 (en) | 2014-09-26 | 2015-09-23 | 1-alkyl-6-oxo-1,6-dihydropyridin-3-yl compounds and use as sgrm modulators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR20170106A true CR20170106A (en) | 2017-09-01 |
Family
ID=54252264
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR20170106A CR20170106A (en) | 2014-09-26 | 2015-09-23 | COMPOUNDS OF 1-ALQUIL-6-OXO-1, 6-DIHIDROPIRIDIN-3-ILO AND USES OF THE SAME |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US10196374B2 (en) |
| EP (1) | EP3197878B1 (en) |
| JP (1) | JP6430000B2 (en) |
| KR (1) | KR101866706B1 (en) |
| CN (1) | CN107001320B (en) |
| AP (1) | AP2017009819A0 (en) |
| AR (1) | AR105549A1 (en) |
| AU (1) | AU2015323817B2 (en) |
| BR (1) | BR112017006085B1 (en) |
| CA (1) | CA2962312C (en) |
| CL (1) | CL2017000715A1 (en) |
| CO (1) | CO2017003955A2 (en) |
| CR (1) | CR20170106A (en) |
| DO (1) | DOP2017000064A (en) |
| EA (1) | EA031945B1 (en) |
| ES (1) | ES2751640T3 (en) |
| GT (1) | GT201700058A (en) |
| IL (1) | IL250886A0 (en) |
| MX (1) | MX2017003697A (en) |
| NI (1) | NI201700038A (en) |
| NZ (1) | NZ730250A (en) |
| PE (1) | PE20171110A1 (en) |
| PH (1) | PH12017500533A1 (en) |
| SG (1) | SG11201702225VA (en) |
| SV (1) | SV2017005412A (en) |
| TN (1) | TN2017000096A1 (en) |
| TW (1) | TW201619146A (en) |
| UY (1) | UY36327A (en) |
| WO (1) | WO2016046260A1 (en) |
| ZA (1) | ZA201702720B (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017161518A1 (en) | 2016-03-23 | 2017-09-28 | Astrazeneca Ab | New physical form |
| TW201927769A (en) | 2017-12-18 | 2019-07-16 | 德商歌林達有限公司 | Substituted pyrrolidine amides II |
| JP2021506964A (en) | 2017-12-18 | 2021-02-22 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | Substituted pyrrolidine amide I |
| KR20210114972A (en) | 2019-01-11 | 2021-09-24 | 그뤼넨탈 게엠베하 | Substituted pyrrolidine amide III |
| WO2020254552A2 (en) | 2019-06-19 | 2020-12-24 | Grünenthal GmbH | Substituted pyrrolidine amides v |
| WO2020254551A1 (en) | 2019-06-19 | 2020-12-24 | Grünenthal GmbH | Substituted pyrrolidine amides iv |
| WO2021136429A1 (en) * | 2019-12-31 | 2021-07-08 | 南京明德新药研发有限公司 | Benzopyrazole compound |
| EP4178954A1 (en) | 2020-07-09 | 2023-05-17 | Grünenthal GmbH | Substituted pyrrolidine amines and amides as mediator of the glucocortoid receptor |
| WO2022012456A1 (en) * | 2020-07-17 | 2022-01-20 | Chengdu Easton Biopharmaceuticals Co., Ltd. | Novel heterocyclic compounds as bet inhibitors |
| WO2023041695A1 (en) | 2021-09-20 | 2023-03-23 | Astrazeneca Ab | Methods of treating inflammatory diseases with a selective glucocorticoid receptor modulator |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2007000615A (en) * | 2004-07-16 | 2007-03-07 | Janssen Pharmaceutica Nv | Dimeric compounds of piperidine, piperazine or morpholine or their 7-membered analogs suitabale for the treatment of neurodegenerative disorders. |
| JO2754B1 (en) * | 2006-12-21 | 2014-03-15 | استرازينكا ايه بي | Indazolyl amide derivatives for the treatment of glucocorticoid receptor mediated disorders |
| TW200951114A (en) * | 2008-05-20 | 2009-12-16 | Astrazeneca Ab | Phenyl or pyridinyl substituted indazoles derivatives |
-
2015
- 2015-09-23 MX MX2017003697A patent/MX2017003697A/en active IP Right Grant
- 2015-09-23 CN CN201580064182.1A patent/CN107001320B/en active Active
- 2015-09-23 KR KR1020177007804A patent/KR101866706B1/en active IP Right Grant
- 2015-09-23 SG SG11201702225VA patent/SG11201702225VA/en unknown
- 2015-09-23 AU AU2015323817A patent/AU2015323817B2/en active Active
- 2015-09-23 CR CR20170106A patent/CR20170106A/en unknown
- 2015-09-23 AP AP2017009819A patent/AP2017009819A0/en unknown
- 2015-09-23 US US15/513,655 patent/US10196374B2/en active Active
- 2015-09-23 ES ES15775130T patent/ES2751640T3/en active Active
- 2015-09-23 CA CA2962312A patent/CA2962312C/en active Active
- 2015-09-23 NZ NZ730250A patent/NZ730250A/en not_active IP Right Cessation
- 2015-09-23 TN TN2017000096A patent/TN2017000096A1/en unknown
- 2015-09-23 BR BR112017006085-0A patent/BR112017006085B1/en active IP Right Grant
- 2015-09-23 JP JP2017515945A patent/JP6430000B2/en active Active
- 2015-09-23 PE PE2017000467A patent/PE20171110A1/en unknown
- 2015-09-23 EP EP15775130.6A patent/EP3197878B1/en active Active
- 2015-09-23 EA EA201790496A patent/EA031945B1/en not_active IP Right Cessation
- 2015-09-23 WO PCT/EP2015/071862 patent/WO2016046260A1/en active Application Filing
- 2015-09-25 AR ARP150103099A patent/AR105549A1/en unknown
- 2015-09-25 UY UY0001036327A patent/UY36327A/en not_active Application Discontinuation
- 2015-09-25 TW TW104131819A patent/TW201619146A/en unknown
-
2017
- 2017-03-02 IL IL250886A patent/IL250886A0/en active IP Right Grant
- 2017-03-08 DO DO2017000064A patent/DOP2017000064A/en unknown
- 2017-03-22 GT GT201700058A patent/GT201700058A/en unknown
- 2017-03-23 PH PH12017500533A patent/PH12017500533A1/en unknown
- 2017-03-24 SV SV2017005412A patent/SV2017005412A/en unknown
- 2017-03-24 NI NI201700038A patent/NI201700038A/en unknown
- 2017-03-24 CL CL2017000715A patent/CL2017000715A1/en unknown
- 2017-04-18 ZA ZA2017/02720A patent/ZA201702720B/en unknown
- 2017-04-24 CO CONC2017/0003955A patent/CO2017003955A2/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DOP2017000064A (en) | COMPOUNDS OF 1-RENT-6-OXO-1,6-DIHIDROPIRIDIN-3-ILO AND USES OF THE SAME | |
| ECSP17081744A (en) | NEW HYDROXYESTER DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM | |
| GT201600147A (en) | DERIVATIVE COMPOUNDS AND COMPOSITIONS OF N-AZASPIROCICLOALCANO N-HETEROARIL REPLACED TO INHIBIT THE ACTIVITY OF SHP2 | |
| CO2017006214A2 (en) | Quinazoline derivatives used to treat HIV | |
| BR112018005497A2 (en) | heterocyclic compounds and their uses | |
| CO2018000589A2 (en) | Oxiesterols and pharmaceutical compositions containing them | |
| NI201600115A (en) | SULFAMOYLPYRROLAMIDE DERIVATIVES AND THEIR USE AS MEDICINES FOR THE TREATMENT OF HEPATITIS B. | |
| CO2017001884A2 (en) | Polymorphs of selinexor | |
| BR112017023161A2 (en) | obeticolic acid compositions and methods of use | |
| BR112017009497A2 (en) | aadc polynucleotides for the treatment of parkinson's disease | |
| UA116648C2 (en) | FUMARATS AS A PRODUCT AND THEIR USE IN THE TREATMENT OF DIFFERENT DISEASES | |
| UY35210A (en) | AUTOTAXIN INHIBITORS | |
| DOP2018000062A (en) | PIRIDINONA DICABOXAMIDS FOR USE AS BROMODOMINUM INHIBITORS | |
| CU20190101A7 (en) | SUBSTITUTED DIAZABICYCLIC IMIDAZOPYRIMIDINES | |
| BR112015022041A2 (en) | Substituted 3-phenylpropylamine derivatives for the treatment of ophthalmic diseases and disorders | |
| UY36224A (en) | TRICYCLIC COMPOUNDS OF IMIDAZO-PIRIMIDINONA | |
| ECSP16074478A (en) | NOVEL COMPOUNDS | |
| CO2017000950A2 (en) | Compounds comprising modified oligonucleotides targeting mir-103 and / or mir-107 for metabolic disorders | |
| CR20170513A (en) | USEFUL PIRAZOL DERIVATIVES AS INHIBITORS OF 5-LI-POXIGENASA ACTIVATING PROTEIN (FLAP). | |
| DOP2016000297A (en) | PHARMACEUTICAL COMPOSITIONS USEFUL TO TREAT INFECTIOUS DISEASES | |
| DOP2018000049A (en) | COMPOUNDS FOR USE IN ANTIBACTERIAL APPLICATIONS | |
| CO2017003994A2 (en) | Derivatives of 4'-vinyl substituted nucleosides as inhibitors of RNA replication of respiratory syncytial virus | |
| PE20160596A1 (en) | FORMULATION OF ATAZANAVIR AND COBICISTAT FOR THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUSES | |
| DOP2016000161A (en) | ASYMMETRIC UREAS P- SUBSTITUTED AND MEDICAL USES OF THE SAME. | |
| BR112016028083A2 (en) | ORAL PHARMACEUTICAL COMPOSITION OF ISOTRETINOIN AND ITS PREPARATION PROCESS |